SACCOMANNI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 10.342
AS - Asia 4.764
EU - Europa 4.219
SA - Sud America 585
AF - Africa 168
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.095
Nazione #
US - Stati Uniti d'America 10.034
IT - Italia 1.666
SG - Singapore 1.411
CN - Cina 1.410
HK - Hong Kong 726
SE - Svezia 623
BR - Brasile 471
VN - Vietnam 360
DE - Germania 354
BG - Bulgaria 330
TR - Turchia 268
CA - Canada 243
FR - Francia 215
FI - Finlandia 195
GB - Regno Unito 193
UA - Ucraina 164
RU - Federazione Russa 155
IN - India 152
AT - Austria 109
JP - Giappone 101
CH - Svizzera 82
KR - Corea 76
BD - Bangladesh 47
CI - Costa d'Avorio 36
AR - Argentina 30
MX - Messico 30
PL - Polonia 29
IQ - Iraq 28
MA - Marocco 28
PK - Pakistan 28
SA - Arabia Saudita 26
ES - Italia 25
ID - Indonesia 25
NG - Nigeria 24
MY - Malesia 17
BE - Belgio 16
EC - Ecuador 16
NL - Olanda 15
CO - Colombia 14
VE - Venezuela 14
ZA - Sudafrica 13
AU - Australia 12
SN - Senegal 12
KE - Kenya 11
PH - Filippine 11
UY - Uruguay 11
CZ - Repubblica Ceca 10
PE - Perù 10
TN - Tunisia 10
EG - Egitto 9
IR - Iran 9
AZ - Azerbaigian 8
JM - Giamaica 8
UZ - Uzbekistan 8
CL - Cile 7
IL - Israele 7
NP - Nepal 7
RS - Serbia 7
AE - Emirati Arabi Uniti 6
BJ - Benin 6
IE - Irlanda 6
JO - Giordania 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
BB - Barbados 5
DZ - Algeria 5
ET - Etiopia 5
GR - Grecia 5
KZ - Kazakistan 5
BO - Bolivia 4
NZ - Nuova Zelanda 4
AL - Albania 3
CR - Costa Rica 3
DM - Dominica 3
GE - Georgia 3
PS - Palestinian Territory 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
GY - Guiana 2
HU - Ungheria 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LT - Lituania 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
ZM - Zambia 2
BH - Bahrain 1
BM - Bermuda 1
BW - Botswana 1
CG - Congo 1
DO - Repubblica Dominicana 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
Totale 20.079
Città #
Woodbridge 1.092
Ann Arbor 914
Ashburn 897
Houston 830
Singapore 817
Hong Kong 713
Fairfield 709
Chandler 604
Santa Clara 548
San Jose 492
Dallas 379
Serra 371
Milan 361
Sofia 330
Beijing 299
Shanghai 293
Seattle 258
Wilmington 256
Jacksonville 234
Cambridge 208
New York 208
Ottawa 195
Izmir 161
Boardman 152
Princeton 141
Los Angeles 134
Lawrence 125
Nanjing 122
Lauterbourg 113
Medford 106
Pisa 106
Vienna 95
Hefei 93
Tokyo 88
Dong Ket 82
Bern 81
Council Bluffs 78
Istanbul 76
Seoul 73
Dearborn 64
Des Moines 63
Ho Chi Minh City 62
Rome 59
Hanoi 56
Munich 54
Buffalo 53
Helsinki 52
Nanchang 52
Marseille 49
Redondo Beach 47
São Paulo 44
The Dalles 44
London 41
Jüchen 40
Redwood City 39
Columbus 38
Pune 38
Abidjan 35
Florence 35
San Diego 35
Shenyang 33
Frankfurt am Main 32
Falls Church 28
Boulder 27
Fuzhou 27
Lucca 26
Pescara 26
Warsaw 25
Lagos 24
Orem 24
Kunming 23
Hangzhou 22
Casablanca 21
Jiaxing 21
Pistoia 20
Ogden 19
San Francisco 19
Genoa 18
Turku 18
Guangzhou 17
Jakarta 17
Tianjin 17
Atlanta 16
Carrara 16
Norwalk 16
Rio de Janeiro 16
Brussels 15
Chennai 15
Da Nang 15
Livorno 15
Quanzhou 15
Changsha 14
Kuala Lumpur 14
Montreal 14
Auburn Hills 13
Bremen 13
Dhaka 13
Hebei 13
Brooklyn 12
Chicago 12
Totale 14.595
Nome #
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells 369
Rutin and quercetin content in the forage of common buckwheat as affected by maturity and conservation method 294
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer 254
Identification of chemical byproducts in the radiofluorination of structurally complex aryliodonium salts 246
Application of An Improved HPLC-FL Method to Screen Serine Palmitoyl Transferase Inhibitors 245
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. 229
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 228
A NEW HPLC METHOD FOR THALIDOMIDE DETECTION IN HUMAN PLASMA 222
Synthesis and antitumor evaluation of 1,8-naphthyridine-2-(1H)-on-3carboxamide derivatives as CB2 selective agonists 221
Anti-proliferative activity of oleocanthal in human malignant cutaneous melanoma cells 221
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor 216
Structural optimization of 4-chlorobenzoylpiperidine derivatives for the development of potent, reversible and selective monoacylglycerol lipase (MAGL) inhibitors 214
Tyrosol-enriched tomatoes by diffusion across the fruit peel from a chitosan coating: a proposal of functional food 212
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 208
Rational design, synthesis, biological evaluation and labelling of selective cannabinoid CB2 receptor agonists as anticancer agents 201
Synthesis and pharmacological evaluation of new biphenylic derivatives as CB2 receptor ligands 201
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands 201
Taurine in women with a history of gestational diabetes, 200
Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligands 200
Development of an HPLC/UV assay for the evaluation of inhibitors of human recombinant monoacylglycerol lipase 199
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 198
SYNTHESIS AND BETA-BLOCKING ACTIVITY OF (R,S)-(E)-OXIMEETHERS OF 2,3-DIHYDRO-1,8-NAPHTHYRIDINE AND 2,3-DIHYDROTHIOPYRANO[2,3-B]PYRIDINE: IDENTIFICATION OF BETA 3-ANTAGONISTS 195
Design, synthesis and preliminary evaluation of (18)F-labelled 1,8-naphthyridin- and quinolin-2-one-3-carboxamide derivatives for PET imaging of CB2 cannabinoid receptor 194
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2 193
Synthesis of 1,8-naphthyridine derivatives: potential antihypertensive agents. Part VIII 192
Sulfonamido-derivatives of unsubstituted carbazoles as BACE1 inhibitors 191
4-[6-(dansylamino)hexylamino]-7-methyl-2-phenyl-1,8-naphthyridine as a new potential fluorescent probe for studying A1-adenosine receptor 191
Design, Synthesis, and In Vitro Evaluation of Novel 8-Amino-Quinoline Combined with Natural Antioxidant Acids 191
CB2-Selective Cannabinoid Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Modeling Investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides 190
Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells 189
Synthesis of 1,8 - naphthyridine derivatives: potential antihypertensive agents. Part VII 184
Design, Synthesis and biological evaluation of new 1,8-naphthyridin-4(1h)-on-3-carboxamide and quinolin-4(1h)-on-3-carboxamide derivatives as CB2 selective agonists 179
Cannabinoid CB2/CB1 Selectivity. Receptor Modeling and Automated Docking Analysis 179
Modified RP-LC of Phenylthiocarbamyl Amino Acid Adducts in Plasma Acetonitrile Extracts using Multiple Internal Standards and Photo-Diode UV Detection. 177
Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology. 176
Rutin content in the forage and grain of common buckwheat (Fagopyrum esculentum) as affected by sowing time and irrigation in a Mediterranean environment. 174
PHARMACOKINETIC OF TRAMADOL AND ITS MAJOR CONJUGATES AFTER SINGLE PER OS ADMINISTRATION OF THE SUSTAINED TABLET AND PER RECTUM SUPPOSITORIES FORMULATIONS IN DOGS 171
EVALUATION OF TRAMADOL AND ITS MAIN METABOLITES IN HORSES PLASMA BY HPLC-FL AND LC-ESI-MS/MS TECHNIQUES 170
Analgesici oppiodi: HPLC-FL e LC-UV-ESI-MS/MS per la determinazione simultanea del tramadolo e dei suoi metaboliti nel plasma di cavallo 170
Effect of frozen-dried grapefruit-juice on the oral administration of tramadol in Beagle dogs 169
A2A receptor ligands: Past, present and future trends 169
Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X 166
Determination of water-soluble vitamins in multivitamin dietary supplements and in artichokes by micellar electrokinetic chromatography. 166
Synthesis and antiplatelet activity of some 3-phenyl-1,8-naphthyridine derivatives 165
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis 163
PHARMACOKINETICS OF INTRAVENOUS AND INTRAMUSCULAR PARECOXIB IN HEALTHY BEAGLES 162
The cannabinoid CB2/CB1 selectivity. Homology modelling and automated docking analysis 161
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 161
A New 4-phenyl-1,8-naphthyridine Derivative Affects Carcinoma Cell Proliferation by Impairing Cell Cycle Progression and Inducing Apoptosis 161
Structure-based virtual screening: Identification of novel CB2 receptor ligands 160
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 160
ASSESSMENT OF THE PHARMACOKINETIC PROFILE OF TRAMADOL AND ITS MAIN METABOLITES IN PLASMA AND URINE FORM DOGS ORALLY ADMINISTERED WITH CONTRAMAL®, WITH OR WITHOUT FREEZE-DRIED GRAPE-FRUIT JUICE 159
1,8-naphthyridine derivatives potent and selective A1 adenosine antagonists 159
Determination of tramadol and metabolites by HPLC-FL and HPLC-MS/MS in urine of dogs 159
HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF THALIDOMIDE IN PATIENTS AFFECTED BY HEPATOCELLULAR CARCINOMA 158
Synthesis and b-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]-pyridine: potential antihypertensive agents. Part IX 158
PHARMACOKINETIC EVALUATION OF TRAMADOL AND ITS MAJOR METABOLITES AFTER SINGLE ORAL SUSTAINED TABLET ADMINISTRATION IN THE DOG: A PILOT STUDY 157
Reduced amino acid levels in patients with primary fibromyalgia. 156
Design, synthesis, and biological evaluation of 1,8-naphthyridin-2(1H)-on-3-carboxamide, quinolin-2(1H)-on-3-carboxamide and 2-oxo-1,2-dihydropyridine-3-carboxamide derivatives as CB2 selective ligands 156
PHARMACOKINETICS OF DIFFERENT FORMULATIONS OF TRAMADOL IN THE HORSE 153
Synthesis and biological evaluation of 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists 152
Pharmacokinetic and urine profile of tramadol and its major metabolites following oral immediate release capsules administration in dogs 152
Carbazole-containing arylcarboxamides as BACE1 inhibitors 151
IN VITRO METABOLISM OF TRAMADOL IN HORSES: PRELIMINARY DATA 150
A NEW RAPID PROCEDURE TO DETECT BY HPLC-FL TRAMADOL AND ITS MAIN METABOLITES IN URINE 150
Adenosine receptor modelling. A1/A2a selectivity 150
Design, synthesis, and biological evaluation of new heterocyclic azotate derivatives as CB2 selective agonists 148
CAN TRAMADOL RECTAL ADMINISTRATION BE USEFUL IN DOG’S PAIN MANAGMENT? A PHARMACOKINETIC STUDY 148
Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives 148
Synthesis of 3- or 4-phenyl-1,8-naphthyridine derivatives and evaluation of antimycobacterial and antimicrobial activity 148
Study on Affinity Profile toward Native and Bovine Adenosine Receptors of a Series of 1,8-Naphthyridine Derivatives 148
Anti-proliferative properties and proapoptotic function of new CB2 selective cannabinoid receptor agonist in jurkat leukemia cells 148
Stereoselective synthesis and beta-blocking activity of substituted (E)- and (Z)- 4(1H) - [1- (3 - alkylamino - 2 - hydroxypropyl) oximino - 2,3 - dihydro - 1,8 - naphthyridine. Potential antihypertensive agents. Part VI 147
Confronto fra le affinità verso i recettori adenosinici umani e bovini di ligandi selettivi 1,8-naftiridinici. 147
18FLUORINE-LABELED NITROGEN HETEROCYCLIC DERIVATIVES AS NEW CANDIDATE FOR CANNABINOID CB2 RECEPTOR PET IMAGING 147
Unusual nitration of substituted 7-amino-1,8-naphthyridine in the synthesis of compounds with antiplatelet activity 147
PHARMACOKINETICS OF THE TRAMADOL INJECTIVE FORMULATIONS IN ALPACAS (VICUGNA PACOS). 147
An unexpected result in the condensation of 2-amino-6-bromo-pyridine with ethyl 4-chloroacetoacetate: four dihalo-substituted pyrido[1,2-a]pyrimidin-4-ones as reaction products 146
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists 146
BIOPHARMACEUTICAL PROFILE OF TRAMADOL IN THE DOG 145
Initial studies on the effect of water in microfluidic radiofluorinations 144
Rational Design, Synthesis, and Pharmacological Properties of New 1,8-Naphthyridin-2(1H)-on-3-Carboxamide Derivatives as Highly Selective Cannabinoid-2 Receptor Agonists 142
ADMINISTRATION OF ORAL SUSTAINED-RELEASE TABLET FORMULATION OF TRAMADOL IN HORSES: PHARMACOKINETICS OF THE PARENTAL DRUG AND OF N-DESMETHYLTRAMADOL 140
A NEW RAPID PROCEDURE TO DETECT BY HPLC-FL TRAMADOL AND ITS MAIN METABOLITES IN DOG’S URINE 140
A novel class of highly potent and selective A(1) adenosine antagonists: Structure-affinity profile of a series of 1,8-naphthyridine derivatives 140
Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors 138
In vivo study of a novel Cannabinoid Type II ligand for PET on a SOD1 mouse model 137
TRAMADOL RECTAL ADMINISTRATION IN DOGS: A PHARMACOKINETIC STUDY 135
PHARMACOKINETICS OF TRAMADOL AFTER EPIDURAL ADMINISTRATION IN HORSES 133
Attività antiproliferativa dell’oleocantale in cellule umane di melanoma cutaneo maligno. 133
Pharmacokinetics of tramadol and its major conjugates after a single per os administration of a sustained tablet and per rectum suppositories formulations in dogs 132
DETERMINATION OF TRAMADOL AND METABOLITES BY HPLC-FL AND LC-MS/MS IN URINE OF DOGS 131
PHARMACOKINETICS OF TRAMADOL AFTER PRE-ADMINISTRATION OF FREEZE-DRIED GRAPEFRUIT JUICE IN BEAGLE DOGS 131
ZASTOSOWANIE TRAMADOLU W INIEKCJI U PSÒW 131
Stereoselective synthesis and beta-blocking activity of substituted (E)- and (Z)-4(1H)-[1-(3-alkylamino-2-hydroxypropyl)oximino]-2,3-dihydro-1,8-naphthyridine. Potential antihypertensive” agents. Part VI 131
Pharmacokinetics of Tramadol and its Metabolites M1, M2 and M5 in Horses Following Intravenous, Immediate Release (Fasted/Fed) and Sustained Release Single Dose Administration 129
Una nuova classe di inibitori delle fosfodiesterasi IV: sintesi e valutazione biologica di derivati 1,8-naftiridinici. 128
Synthesis of variously 1,8-naphthyridine derivatives and evaluation of their antimicobacterial activity 128
Preliminary Investigation of a Novel 18F Radiopharmaceutical for Imaging CB2 Receptors in a SOD Mouse Model 126
Synthesis of 18F-labeled nitrogen heterocyclic derivatives as new candidate for cannabinoid CB2 receptor PET imaging 125
Totale 17.102
Categoria #
all - tutte 53.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.111


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 0 0 0 0 0 0 0 0 0 0 64 177
2021/20221.468 41 155 44 67 252 192 80 82 36 27 96 396
2022/20231.887 222 248 127 188 221 267 11 134 319 17 73 60
2023/20241.419 222 173 154 107 198 214 110 19 20 32 40 130
2024/20253.952 17 166 57 282 413 465 253 237 375 497 411 779
2025/20264.123 346 539 460 395 387 434 673 200 246 332 111 0
Totale 20.359